Sachit Sharma1, Deema Sallout2, Ashu Acharya1, Douglas G Adler3. 1. Department of Internal Medicine, The University of Toledo Medical Center, Toledo, OH, USA. 2. Department of Internal Medicine, The University of Utah School of Medicine, Salt Lake City, UT, USA. 3. Center for Advanced Therapeutic Endoscopy, Centura Health, Denver, CO, USA. dougraham2001@gmail.com.
Abstract
INTRODUCTION: Lower gastrointestinal bleeding (LGIB) is one of the most common indications for hospital admission. The current standard of care for patients admitted with LGIB includes colonoscopy. The aims of this study are to define the rate of readmission in patients with LGIB and to determine whether early colonoscopy within the first 24 h after admission impacts the rate of readmission in these patients. METHODS: We performed a retrospective cohort study on data obtained from the Nationwide Readmission Database and identified patients admitted with lower GI bleed using ICD-10 codes. The primary outcome was 30-day all-cause readmission, and one of our secondary outcomes was the impact of early colonoscopy on 30-day readmission. RESULTS: We analyzed data from 35,790,513 patients who were admitted for LGIB in 2017. A total of 16.4% of these patients were readmitted within 30 days of discharge, with diverticular bleeding most common diagnosis for readmission. Overall, in-hospital mortality was 1.18% for index admission and 4.44% for readmission. Early colonoscopy did not impact the rate of readmission within 30 days of discharge. CONCLUSION: LGIB remains a commonly encountered in clinical practice with a high readmission rate. Mortality is significantly higher during readmission compared to index admission. Early colonoscopy did not impact the 30-day readmission rate.
INTRODUCTION: Lower gastrointestinal bleeding (LGIB) is one of the most common indications for hospital admission. The current standard of care for patients admitted with LGIB includes colonoscopy. The aims of this study are to define the rate of readmission in patients with LGIB and to determine whether early colonoscopy within the first 24 h after admission impacts the rate of readmission in these patients. METHODS: We performed a retrospective cohort study on data obtained from the Nationwide Readmission Database and identified patients admitted with lower GI bleed using ICD-10 codes. The primary outcome was 30-day all-cause readmission, and one of our secondary outcomes was the impact of early colonoscopy on 30-day readmission. RESULTS: We analyzed data from 35,790,513 patients who were admitted for LGIB in 2017. A total of 16.4% of these patients were readmitted within 30 days of discharge, with diverticular bleeding most common diagnosis for readmission. Overall, in-hospital mortality was 1.18% for index admission and 4.44% for readmission. Early colonoscopy did not impact the rate of readmission within 30 days of discharge. CONCLUSION: LGIB remains a commonly encountered in clinical practice with a high readmission rate. Mortality is significantly higher during readmission compared to index admission. Early colonoscopy did not impact the 30-day readmission rate.
Authors: Raquel E Davila; Elizabeth Rajan; Douglas G Adler; James Egan; William K Hirota; Jonathan A Leighton; Waqar Qureshi; Marc J Zuckerman; Robert Fanelli; Jo Wheeler-Harbaugh; Todd H Baron; Douglas O Faigel Journal: Gastrointest Endosc Date: 2005-11 Impact factor: 9.427
Authors: Kathryn Oakland; Richard Guy; Raman Uberoi; Rachel Hogg; Neil Mortensen; Michael F Murphy; Vipul Jairath Journal: Gut Date: 2017-02-01 Impact factor: 23.059
Authors: Shabana F Pasha; Amandeep Shergill; Ruben D Acosta; Vinay Chandrasekhara; Krishnavel V Chathadi; Dayna Early; John A Evans; Deborah Fisher; Lisa Fonkalsrud; Joo Ha Hwang; Mouen A Khashab; Jenifer R Lightdale; V Raman Muthusamy; John R Saltzman; Brooks D Cash Journal: Gastrointest Endosc Date: 2014-04-02 Impact factor: 9.427
Authors: Omar Kherad; Sophie Restellini; Majid Almadi; Lisa L Strate; Charles Ménard; Myriam Martel; Ira Roshan Afshar; Mohamad Seyed Sadr; Alan N Barkun Journal: Aliment Pharmacol Ther Date: 2020-07-22 Impact factor: 8.171
Authors: Fernando S Velayos; Ann Williamson; Karen H Sousa; Edward Lung; Alan Bostrom; Ellen J Weber; James W Ostroff; Jonathan P Terdiman Journal: Clin Gastroenterol Hepatol Date: 2004-06 Impact factor: 11.382